%0 Journal Article
%T Successful Treatment of Erythrodermic Mycosis Fungoides with Mogamulizumab Followed by Etoposide Monotherapy
%A Akira Hashimoto
%A Akira Tsukada
%A Kayo Tanita
%A Sadanori Furudate
%A Setsuya Aiba
%A Taku Fujimura
%A Yota Sato
%A Yumi Kambayashi
%J Archive of "Case Reports in Oncology".
%D 2018
%R 10.1159/000486278
%X Mogamulizumab induces cytotoxicity against CCR4+ lymphoma cells by antibody-dependent cell-mediated cytotoxicity in advanced cutaneous T-cell lymphoma patients. Since the efficacy of mogamulizumab in mycosis fungoides (28.6%) is lower than that in S¨¦zary syndrome (47.1%), reagents that enhance the antitumor immune response induced by mogamulizumab are needed to further optimize its use for the treatment of erythrodermic mycosis fungoides. In this report, we present a case of erythrodermic mycosis fungoides successfully treated with mogamulizumab followed by etoposide monotherapy
%K Erythrodermic mycosis fungoides
%K Mogamulizumab
%K Etoposide
%U https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5836287/